Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome

[1]  F. Lang,et al.  Enhanced programmed cell death of iron‐deficient erythrocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  G. Remuzzi,et al.  Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management? , 2005, Nature Clinical Practice Nephrology.

[3]  Evelin Schwarzer,et al.  Band 3/Complement-mediated Recognition and Removal of Normally Senescent and Pathological Human Erythrocytes , 2005, Cellular Physiology and Biochemistry.

[4]  G. Bosman,et al.  Erythrocyte Aging: A More than Superficial Resemblance to Apoptosis? , 2005, Cellular Physiology and Biochemistry.

[5]  J. Goodship,et al.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[6]  C. Alfrey,et al.  The Negative Regulation of Red Cell Mass by Neocytolysis: Physiologic and Pathophysiologic Manifestations , 2005, Cellular Physiology and Biochemistry.

[7]  Florian Lang,et al.  Mechanisms of Suicidal Erythrocyte Death , 2005, Cellular Physiology and Biochemistry.

[8]  S. Laufer,et al.  PGE2 in the regulation of programmed erythrocyte death , 2005, Cell Death and Differentiation.

[9]  N. Avent,et al.  Expression of phosphatidylserine (PS) on wild‐type and Gerbich variant erythrocytes following glycophorin‐C (GPC) ligation , 2005, British journal of haematology.

[10]  Takao Shimizu,et al.  Stimulation of erythrocyte ceramide formation by platelet-activating factor , 2005, Journal of Cell Science.

[11]  P. Matarrese,et al.  Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  W. Fridman,et al.  Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[13]  R. Weber,et al.  Erythrocyte Signal Transduction Pathways, their Oxygenation Dependence and Functional Significance , 2005, Cellular Physiology and Biochemistry.

[14]  M. Bitzan,et al.  Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[15]  F. Lang,et al.  Cl- Channel Blockers NPPB and Niflumic Acid Blunt Ca2+-induced Erythrocyte ‘Apoptosis’ , 2004, Cellular Physiology and Biochemistry.

[16]  W. Fridman,et al.  Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.

[17]  F. Lang,et al.  Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl-. , 2004, American journal of physiology. Renal physiology.

[18]  M. Perretti,et al.  Annexin 1 and neutrophil apoptosis. , 2004, Biochemical Society transactions.

[19]  J. Atkinson,et al.  Mutations in CD46, a complement regulatory protein, predispose to atypical HUS. , 2004, Trends in molecular medicine.

[20]  H. Northoff,et al.  Effect of Vibrio parahaemolyticus haemolysin on human erythrocytes , 2004, Cellular microbiology.

[21]  C. Danielson,et al.  Drug‐induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise Review , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[22]  G. Deschênes,et al.  Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.

[23]  F. Lang,et al.  Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes , 2004, Cell Death and Differentiation.

[24]  F. Lang,et al.  Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. , 2003, American journal of physiology. Cell physiology.

[25]  G. Remuzzi,et al.  Familial haemolytic uraemic syndrome and an MCP mutation , 2003, The Lancet.

[26]  T. Risler,et al.  Inhibition of erythrocyte cation channels by erythropoietin. , 2003, Journal of the American Society of Nephrology : JASN.

[27]  Wu-chang Yang,et al.  Tacrolimus-associated hemolytic uremic syndrome: a case analysis. , 2003, Journal of nephrology.

[28]  P. Low,et al.  Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. , 2003, Blood.

[29]  H. Tsai.  Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. , 2003, Journal of the American Society of Nephrology : JASN.

[30]  F. Lang,et al.  Cation channels trigger apoptotic death of erythrocytes , 2003, Cell Death and Differentiation.

[31]  P. Low,et al.  Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells. , 2002, Blood.

[32]  P. Low,et al.  Protein kinase C activation induces phosphatidylserine exposure on red blood cells. , 2002, Biochemistry.

[33]  P. Stricklett,et al.  Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. , 2002, Journal of the American Society of Nephrology : JASN.

[34]  D. Dekkers,et al.  Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. , 2002, The Biochemical journal.

[35]  J. Moake,et al.  Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. , 2000, Current opinion in pediatrics.

[36]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[37]  G. Kroemer,et al.  Erythrocytes: Death of a mummy , 2001, Cell Death and Differentiation.

[38]  I. H. Engels,et al.  Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis , 2001, Cell Death and Differentiation.

[39]  C. Slomianny,et al.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria , 2001, Cell Death and Differentiation.

[40]  J. Corrigan,et al.  Hemolytic-uremic syndrome. , 2001, Pediatrics in review.

[41]  C. Czerny,et al.  Chemotherapy-Related Hemolytic-Uremic Syndrome following Treatment of a Carcinoma of the Nasopharynx , 2001, Oncology.

[42]  L. V. D. Heuvel,et al.  Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. , 2001, Journal of the American Society of Nephrology : JASN.

[43]  V. Fadok,et al.  A receptor for phosphatidylserine-specific clearance of apoptotic cells , 2000, Nature.

[44]  J. Dachary-Prigent,et al.  Phosphatidylserine‐related adhesion of human erythrocytes to vascular endothelium , 1999, British journal of haematology.

[45]  G. Remuzzi,et al.  Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. , 1999, Journal of the American Society of Nephrology : JASN.

[46]  E. Kable,et al.  Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts. , 1999, Cell calcium.

[47]  P. Low,et al.  Role of red blood cells in thrombosis. , 1999, Current opinion in hematology.

[48]  B. Weksler,et al.  Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. , 1999, Blood.

[49]  F. Boas,et al.  Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Meier‐Kriesche,et al.  The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent , 1998, Clinical pharmacology and therapeutics.

[51]  R. Kolesnick,et al.  Regulation of ceramide production and apoptosis. , 1998, Annual review of physiology.

[52]  J. Dichgans,et al.  Fas/CD95/Apo-I activates the acidic sphingomyelinase via Caspases , 1998, Cell Death and Differentiation.

[53]  N. Mohandas,et al.  Regulation of CD44-Protein 4.1 Interaction by Ca2+and Calmodulin , 1997, The Journal of Biological Chemistry.

[54]  E. Jaffe,et al.  Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. , 1997, Blood.

[55]  A. Brovelli,et al.  Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes. , 1996, The Biochemical journal.

[56]  E. Jaffe,et al.  Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. , 1996, Blood.

[57]  D. Swerdlow,et al.  Escherichia coli O157:H7 and the hemolytic-uremic syndrome. , 1995, The New England journal of medicine.

[58]  D. Green,et al.  FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. , 1995, Immunity.

[59]  P. Gascard,et al.  Regulation and post-translational modification of erythrocyte membrane and membrane-skeletal proteins. , 1992, Seminars in hematology.

[60]  D Josef,et al.  The gel test: a new way to detect red cell antigen‐antibody reactions , 1990, Transfusion.

[61]  N. Mohandas,et al.  Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions. , 1988, The Journal of clinical investigation.

[62]  M. Petric,et al.  ESCHERICHIA COLI CYTOTOXIN, HAEMOLYTIC-URAEMIC SYNDROME, AND HAEMORRHAGIC COLITIS , 1983, The Lancet.

[63]  K. Carraway,et al.  Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease. , 1977, The Journal of biological chemistry.

[64]  R. Michell,et al.  Release of diacylglycerol-enriched vesicles from erythrocytes with increased intracellular [Ca2+] , 1976, Nature.

[65]  M. Polley,et al.  Optimal Conditions for Detecting Blood Group Antibodies by the Antiglobulin Test , 1964, Vox sanguinis.